Canadian governments OK settlement with Purdue Pharma over opioid addictions
VANCOUVER — British Columbia says a proposed $150-million settlement with Purdue Pharma Canada has been reached for the recovery of health-care costs related to the sale and marketing of opioid-based pain medication.
Attorney General David Eby says it’s the largest settlement of a governmental health care cost claim in Canadian history.
The province launched a class-action lawsuit in 2018 against more than 40 drug companies on behalf of all federal, provincial and territorial governments with the aim of recovering health-care costs for the “wrongful conduct of opioid manufacturers, distributors and their consultants.”
Eby says the proposed settlement was accepted by all governments across Canada.